Time on boards
- Boards served
- 1
- Current seats
- 1
- Board service
- 4 years
- Director since
- 2023
4 years of board service in total across 1 board, counting each seat separately. Longest: Immunovant Inc., 3 years.
Immunovant Inc.
Director
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Aug 28, 2026 | Immunovant Inc. | Option exercise | +1,500 | $8.43 | $12,645 |
| Aug 28, 2026 | Immunovant Inc. | Open-market sale | −1,500 | $43.27 | $64,905 |
| Jul 24, 2026 | Immunovant Inc. | Option exercise | +1,500 | $8.43 | $12,645 |
| Jul 24, 2026 | Immunovant Inc. | Open-market sale | −1,500 | $39.80 | $59,700 |
| Jun 26, 2026 | Immunovant Inc. | Option exercise | +1,500 | $8.43 | $12,645 |
| Jun 26, 2026 | Immunovant Inc. | Open-market sale | −1,500 | $38.01 | $57,015 |
| Jun 15, 2026 | Immunovant Inc. | Option exercise | +1,500 | $8.43 | $12,645 |
| Jun 15, 2026 | Immunovant Inc. | Open-market sale | −1,500 | $34.02 | $51,030 |
| May 20, 2026 | Immunovant Inc. | Option exercise | +6,000 | $8.43 | $50,580 |
| May 20, 2026 | Immunovant Inc. | Open-market sale | −6,000 | $32.00 | $192,000 |
| Apr 7, 2026 | Immunovant Inc. | Grant or award | +13,880 | — | — |
| Apr 1, 2025 | Immunovant Inc. | Grant or award | +16,188 | — | — |
| Dec 2, 2024 | Immunovant Inc. | Open-market sale | −7,750 | $28.54 | $221,185 |
| Apr 2, 2024 | Immunovant Inc. | Grant or award | +11,255 | — | — |
| Dec 1, 2023 | Immunovant Inc. | Open-market sale | −4,129 | $38.80 | $160,205 |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.